This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Nathan Thomsen
Senior Research Scientist II at Gilead Sciences


Nathan joined Gilead in 2014 and has played a leading role in establishing antibody engineering capabilities at Gilead Sciences.  Nathan's research group supports project teams across therapeutic areas, and since 2016 he has served as both a research and development project team lead for Gilead's HIV broadly neutralizing antibody program. Before joining Gilead, Nathan was a Damon Runyon Postdoctoral Fellow with Jim Wells at UC San Francisco and earned a Ph.D. in structural biology with James Berger at UC Berkeley.

Agenda Sessions

  • Engineering Effector Enhanced HIV Broadly Neutralizing Antibodies for HIV Cure